CD34 and infection: We performed a time‐course RNA‐Seq analysis on cord blood (CB)‐derived CD34+ cells pre‐stimulated with early‐acting cytokines for 24 h and then exposed to either research‐ or clinical‐grade VSV‐g pseudotyped (SIN) LV at a high multiplicity of infection, matching current clinical vector dose requirements.